Showing results (1241-1250 of 7,024) with videos related to

Sort By:
Pageof 703
American Journal of Hypertension|January 11, 2021
Associations Between Social Determinants and Hypertension, Stage 2 Hypertension, and Controlled Blood Pressure Among Men and Women in the United StatesYvonne Commodore-Mensah, Ruth-Alma Turkson-Ocran, Kathryn Foti, et al.
American Journal of Hypertension|June 7, 2021
Self-Measured Blood Pressure Monitoring Among Adults With Self-Reported Hypertension in 20 US States and the District of Columbia, 2019Jing Fang, Cecily Luncheon, Hilary K Wall, et al.
American Journal of Hypertension|November 17, 2020
Twenty-Five-Year Changes in Office and Ambulatory Blood Pressure: Results From the Coronary Artery Risk Development in Young Adults (CARDIA) StudyJoshua D Bundy, Byron C Jaeger, Mark D Huffman, et al.
American Journal of Hypertension|December 17, 2020
Hypertension in Chronic Kidney Disease (CKD): Diagnosis, Classification, and Therapeutic TargetsPanagiotis I Georgianos, Rajiv Agarwal
American Journal of Hypertension|February 16, 2020
Arterial Stiffness in Hypertension and Function of Large ArteriesYi Zhang, Patrick Lacolley, Athanase D Protogerou, et al.
American Journal of Hypertension|February 16, 2020
Chronic Dantrolene Treatment Does Not Affect Hypertension, but Attenuates Sympathetic Stimulation Enhanced Atrial Fibrillation Inducibility in SHRJae S Lee, Lisa Greco, Allan Migirov, et al.
American Journal of Hypertension|March 5, 2020
Vascular α1-Adrenergic Receptor Responsiveness in Masked HypertensionYuichiro Yano, Anthony J Viera, Alan L Hinderliter, et al.
American Journal of Hypertension|May 26, 2021
A Novel Peptide Ameliorates TNFα- and LPS-Induced Endothelia Dysfunction in PreeclampsiaXiaohong Ji, Chanjuan Li, Yan Lv, et al.
American Journal of Hypertension|January 15, 2014
Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertensionCongcong Zhang, Yulin Li, Chunxiao Wang, et al.
American Journal of Hypertension|May 21, 2014
Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blockerMasato Furuhashi, Norihito Moniwa, Tomohiro Mita, et al.
Pageof 703